过去一年中添加的文章，按日期排序
[HTML][HTML] Application of Photodynamic Therapy with 5-Aminolevulinic Acid to Extracorporeal Photopheresis in the Treatment of Cutaneous T-Cell Lymphoma: A First-in …
E Christensen, OA Foss, T Holien, P Juzenas, Q Peng - Pharmaceutics, 2024 - mdpi.com
3 天前 - Extracorporeal photopheresis (ECP) is a therapeutic modality used for T-cell-mediated
disorders. This approach involves exposing isolated white blood cells to …
disorders. This approach involves exposing isolated white blood cells to …
Resminostat for Maintenance Treatment in Patients with Advanced Stage Mycosis Fungoides or Sézary Syndrome: A Multicentre, Double-Blind, Randomised, Placebo …
R Stadler, P Quaglino, S Woei-A-Jin, R Dummer… - papers.ssrn.com
7 天前 - … The patients had received at least one prior systemic therapy according to local
standards (including but not limited to α interferon, bexarotene, extracorporeal photopheresis, …
standards (including but not limited to α interferon, bexarotene, extracorporeal photopheresis, …
Chart review study of real-world clinical outcomes in patients with cutaneous T-cell lymphoma treated with extracorporeal photopheresis in the US in 2017–2019
9 天前 - … patterns and response rates of extracorporeal photopheresis (ECP) in CTCL patients.
… For patients who are unresponsive to other treatments, extracorporeal photopheresis (…
… For patients who are unresponsive to other treatments, extracorporeal photopheresis (…
Early extracorporeal photopheresis treatment is associated with better survival in patients with chronic or recurrent acute lung allograft dysfunction
F Gautschi, T Vogelmann, G Ortmanns… - Journal of Clinical …, 2024 - Wiley Online Library
16 天前 - … Treatment options for slowing down CLAD progression are scarce with extracorporeal
photopheresis (ECP) as an established rescue therapy. The aim of the study was to …
photopheresis (ECP) as an established rescue therapy. The aim of the study was to …
Racial differences in therapies received by patients with cutaneous T cell lymphoma (CTCL): A single center retrospective cohort analysis.
K Case, A Marra, JM Switchenko, D Paulino, B Adams… - 2024 - ascopubs.org
21 天前 - … Black patients were less likely to receive photopheresis and local radiation
compared to white patients (36.73% vs. 63.27% and 39.53% vs. 60.47%, p < 0.05, respectively), …
compared to white patients (36.73% vs. 63.27% and 39.53% vs. 60.47%, p < 0.05, respectively), …
[HTML][HTML] Sézary Syndrome in West Sweden: Exploring Epidemiology, Clinical Features, and Treatment Patterns in a Registry-Based Retrospective Analysis
K Wojewoda, M Gillstedt, C Lewerin, A Osmancevic - Cancers, 2024 - mdpi.com
29 天前 - … Notably, triple therapy involving retinoids, interferon alpha, and extracorporeal
photopheresis (ECP) exhibited the longest median time to the next treatment, at 14.1 months. …
photopheresis (ECP) exhibited the longest median time to the next treatment, at 14.1 months. …
Treatment of Acute and Chronic Graft-Versus-Host Disease with Extracorporeal Photopheresis: Update of Best Practice Recommendations from Italian Society of …
A COLPO, M Marchetti, I Bianco, F Cruciani… - … Stem Cells and Cell … - papers.ssrn.com
33 天前 - … Available second line options include extracorporeal photopheresis (ECP).ECP
is an autologous immunomodulatory cell therapy which involves three different phases: …
is an autologous immunomodulatory cell therapy which involves three different phases: …
[HTML][HTML] A novel web-based tool for lung transplant patients undergoing extracorporeal photopheresis
D Bennett, M Fanetti, M Messina, BT Corradini… - JHLT Open, 2024 - Elsevier
40 天前 - Background Extracorporeal photopheresis (ECP) is considered an emerging rescue
therapy for patients with chronic lung allograft dysfunction (CLAD). The aim of the study …
therapy for patients with chronic lung allograft dysfunction (CLAD). The aim of the study …
The value of extracorporeal photopheresis as an immunosuppression-modifying approach in solid organ transplantation: a potential solution to an unmet medical …
JF Augusto, C Benden, F Diekmann… - Frontiers in …, 2024 - frontiersin.org
43 天前 - … Extracorporeal photopheresis (ECP) has shown potential as an immunosuppression
(IS)-modifying technique in several SOT types, with improvements seen in acute and …
(IS)-modifying technique in several SOT types, with improvements seen in acute and …
Clinical Characteristics and Outcomes of Lung Transplant Recipients Receiving Extracorporeal Photopheresis (ECP) for Chronic Allograft Dysfunction (CLAD)
JG Rim, AJ Gordee, CL Green, CW Frankel… - B47. LUNG …, 2024 - atsjournals.org
49 天前 - RATIONALE: CLAD is the leading cause of late mortality and graft loss in lung
recipients. ECP has been explored as a salvage treatment for CLAD, but significant uncertainty …
recipients. ECP has been explored as a salvage treatment for CLAD, but significant uncertainty …